\-\ Texto\\:\\ \ \(0\)\
\-\ palpable\\ mass\\ left\\ breast\\ 0800\\.\ \(0\)\
\-\ pt\\ had\\ a\\ left\\ breast\\ mastectomy\\ and\\ sentinel\\ node\\ biopsy\\.sentinel\\ node\\ negative\\;\\ touch\\ prep\\ diagnosis\\ of\\ post\\ mastectomy\\:\\ no\\ metastatic\\ carcinoma\\ identified\\.\ \(0\)\
\-\ \\:\\ routine\\ 2\\-view\\ mammography\\ with\\ palpable\\ mass\\ tagged\\ on\\ left\\ breast\\â\\€\\”breast\\ tissue\\ dense\\,\\ poorly\\ defined\\ 2\\.2cm\\ mass\\ at\\ 0800\\ position\\ in\\ posterior\\ third\\ of\\ left\\ breast\\.\\ no\\ other\\ films\\ for\\ comparison\\.\\ transverse\\/longitudinal\\ us\\â\\€\\”lobulated\\ mass\\ with\\ irregular\\ borders\\ measuring\\ approximately\\ 2\\ x\\ 1cm\\ in\\ size\\.\ \(0\)\
\-\ infiltrating\\ ductal\\ carcinoma\ \(11\)\
\-\ malignancy\\ \\(invasive\\ carcinoma\\ \\(ductal\\/lobular\\)\\,\\ fibroadenoma\\,\\ phyllodes\\ tumor\ \(0\)\
\-\ 39\\ y\\/o\\ female\\ presented\\ with\\ a\\ palpable\\ mass\\ on\\ left\\ breast\\ at\\ 0800\\ position\ \(1\)\
\-\ according\\ to\\ the\\ american\\ cancer\\ society\\ \\,\\ almost\\ 217\\,000\\ new\\ cases\\ of\\ breast\\ cancer\\ will\\ be\\ diagnosed\\ by\\ the\\ end\\ of\\ 2004\\.\\ the\\ most\\ common\\ form\\ of\\ breast\\ cancer\\,\\ accounting\\ for\\ more\\ than\\ 75\\ percent\\ of\\ diagnoses\\,\\ is\\ infiltrating\\ \\(invasive\\)\\ ductal\\ carcinoma\\.\\ this\\ cancer\\ originates\\ within\\ the\\ mammary\\ ducts\\ and\\ penetrates\\ through\\ the\\ ductal\\ walls\\ invading\\ into\\ the\\ surrounding\\ fatty\\ tissue\\ of\\ the\\ breast\\.\\ this\\ 39\\-year\\-old\\ woman\\ found\\ a\\ palpable\\ mass\\ that\\ turned\\ out\\ to\\ be\\ a\\ breast\\ cancer\\.\\ because\\ this\\ patient\\ had\\ fibrocystic\\ changes\\ of\\ her\\ breast\\,\\ the\\ mammogram\\ was\\ not\\ very\\ definitive\\,\\ but\\ the\\ ultrasound\\ was\\ very\\ important\\ in\\ distinguishing\\ the\\ malignancy\\ potential\\ of\\ the\\ mass\\.\\ as\\ an\\ adjunct\\ to\\ mammography\\,\\ ultrasound\\ has\\ become\\ an\\ important\\ tool\\ in\\ evaluating\\ the\\ breast\\ \\.only\\ about\\ 25\\%\\ of\\ breast\\ carcinomas\\ will\\ metastasize\\ to\\ a\\ distant\\ site\\ with\\,\\ unfortunately\\,\\ 95\\%\\ of\\ those\\ patients\\ dying\\ from\\ their\\ metastatic\\ disease\\.\\ metastasis\\ of\\ the\\ breast\\ to\\ varying\\ distant\\ sites\\ is\\ by\\ way\\ of\\ the\\ angiolymphatic\\ system\\,\\ making\\ it\\ very\\ important\\ to\\ monitor\\ lymph\\ nodes\\ and\\ lymphatic\\ ductal\\ invasion\\ on\\ gross\\ specimen\\.\\ axillary\\ lymph\\ nodes\\ are\\ the\\ first\\ nodes\\ seeding\\ with\\ breast\\ carcinoma\\ metastasis\\.\\ for\\ this\\ patient\\,\\ her\\ sentinel\\ lymph\\ node\\ was\\ negative\\.\\ current\\ success\\ rates\\ for\\ the\\ predictive\\ value\\ of\\ sentinel\\ node\\ biopsy\\ are\\ variable\\ with\\ the\\ surgeon\\ performing\\ the\\ procedure\\ and\\ the\\ characteristics\\ of\\ the\\ patient\\ involved\\ \\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ breast\\:\\ 0\\.515809822030204\ \(0\)\
\-\ sentinel\\:\\ 0\\.23830411391922496\ \(0\)\
\-\ 0800\\:\\ 0\\.22718952055081196\ \(0\)\
\-\ ductal\\:\\ 0\\.20836043286052897\ \(0\)\
\-\ the\\:\\ 0\\.18897798787938042\ \(0\)\
\-\ node\\:\\ 0\\.1628077877818231\ \(0\)\
\-\ cancer\\:\\ 0\\.15770657172678373\ \(0\)\
\-\ carcinoma\\:\\ 0\\.14162601967880498\ \(0\)\
\-\ of\\:\\ 0\\.13900541360158694\ \(0\)\
\-\ palpable\\:\\ 0\\.13307252349108184\ \(0\)\
\-\ mass\\:\\ 0\\.12661655832943292\ \(0\)\
\-\ nodes\\:\\ 0\\.1206823533414696\ \(0\)\
\-\ important\\:\\ 0\\.12033884098258124\ \(0\)\
\-\ lymph\\:\\ 0\\.1104695170596589\ \(0\)\
\-\ very\\:\\ 0\\.1019102310482616\ \(0\)\
\-\ mastectomy\\:\\ 0\\.10052130642893249\ \(0\)\
\-\ distant\\:\\ 0\\.09904452607364814\ \(0\)\
\-\ mammography\\:\\ 0\\.09869497981317985\ \(0\)\
\-\ infiltrating\\:\\ 0\\.09291210154707644\ \(0\)\
\-\ invasive\\:\\ 0\\.08618023161770787\ \(0\)\
\-\ left\\:\\ 0\\.08076792842055167\ \(0\)\
\-\ 39\\:\\ 0\\.07870561906390132\ \(0\)\
\-\ angiolymphatic\\:\\ 0\\.07572984018360399\ \(0\)\
\-\ position\\:\\ 0\\.0755065128667291\ \(0\)\
\-\ penetrates\\:\\ 0\\.07236390521891971\ \(0\)\
\-\ to\\:\\ 0\\.07103089697752774\ \(0\)\
\-\ malignancy\\:\\ 0\\.07090222677405375\ \(0\)\
\-\ phyllodes\\:\\ 0\\.06997573635552154\ \(0\)\
\-\ metastasis\\:\\ 0\\.06941441096863558\ \(0\)\
\-\ dying\\:\\ 0\\.06812332867236288\ \(0\)\
\-\ biopsy\\:\\ 0\\.06638735640558434\ \(0\)\
\-\ prep\\:\\ 0\\.06533013230788869\ \(0\)\
\-\ this\\:\\ 0\\.06508716570484427\ \(0\)\
\-\ will\\:\\ 0\\.06095699316779173\ \(0\)\
\-\ seeding\\:\\ 0\\.060855697562754815\ \(0\)\
\-\ fibrocystic\\:\\ 0\\.060191229663942455\ \(0\)\
\-\ predictive\\:\\ 0\\.060191229663942455\ \(0\)\
\-\ adjunct\\:\\ 0\\.05957602847980624\ \(0\)\
\-\ tool\\:\\ 0\\.05957602847980624\ \(0\)\
\-\ her\\:\\ 0\\.059168564947810844\ \(0\)\
\-\ negative\\:\\ 0\\.05863345099027298\ \(0\)\
\-\ tagged\\:\\ 0\\.05846752869935666\ \(0\)\
\-\ society\\:\\ 0\\.05846752869935666\ \(0\)\
\-\ ultrasound\\:\\ 0\\.0584180265800517\ \(0\)\
\-\ turned\\:\\ 0\\.05796425842970311\ \(0\)\
\-\ metastasize\\:\\ 0\\.05796425842970311\ \(0\)\
\-\ distinguishing\\:\\ 0\\.05748976259807053\ \(0\)\
\-\ for\\:\\ 0\\.0574109037144148\ \(0\)\
\-\ mammary\\:\\ 0\\.057040928045163954\ \(0\)\
\-\ accounting\\:\\ 0\\.056210093515121955\ \(0\)\
\-\ originates\\:\\ 0\\.056210093515121955\ \(0\)\
\-\ with\\:\\ 0\\.05563538772123628\ \(0\)\
\-\ invading\\:\\ 0\\.05510159373467237\ \(0\)\
\-\ lymphatic\\:\\ 0\\.05412382763338625\ \(0\)\
\-\ performing\\:\\ 0\\.05324918605151371\ \(0\)\
\-\ carcinomas\\:\\ 0\\.052976984057017396\ \(0\)\
\-\ fibroadenoma\\:\\ 0\\.05196951696856513\ \(0\)\
\-\ metastatic\\:\\ 0\\.05194293309751187\ \(0\)\
\-\ success\\:\\ 0\\.05128682421708151\ \(0\)\
\-\ specimen\\:\\ 0\\.05045598968703951\ \(0\)\
\-\ 1cm\\:\\ 0\\.050260653214466246\ \(0\)\
\-\ diagnoses\\:\\ 0\\.050069807635731226\ \(0\)\
\-\ varying\\:\\ 0\\.04970079501568822\ \(0\)\
\-\ tissue\\:\\ 0\\.04968200041424566\ \(0\)\
\-\ way\\:\\ 0\\.04952226303682407\ \(0\)\
\-\ was\\:\\ 0\\.049510330683740056\ \(0\)\
\-\ rates\\:\\ 0\\.04934748990658992\ \(0\)\
\-\ ducts\\:\\ 0\\.04884421963693638\ \(0\)\
\-\ unfortunately\\:\\ 0\\.04884421963693638\ \(0\)\
\-\ monitor\\:\\ 0\\.048369723805303806\ \(0\)\
\-\ value\\:\\ 0\\.048217399952572564\ \(0\)\
\-\ borders\\:\\ 0\\.04763460512211088\ \(0\)\
\-\ according\\:\\ 0\\.04763460512211088\ \(0\)\
\-\ evaluating\\:\\ 0\\.04763460512211088\ \(0\)\
\-\ making\\:\\ 0\\.047357865594264345\ \(0\)\
\-\ had\\:\\ 0\\.04718731007597919\ \(0\)\
\-\ in\\:\\ 0\\.047120855366476255\ \(0\)\
\-\ percent\\:\\ 0\\.0468306143246189\ \(0\)\
\-\ axillary\\:\\ 0\\.04657903697938383\ \(0\)\
\-\ touch\\:\\ 0\\.04645605077353822\ \(0\)\
\-\ sites\\:\\ 0\\.046215413140482685\ \(0\)\
\-\ patient\\:\\ 0\\.046205932959520114\ \(0\)\
\-\ variable\\:\\ 0\\.045981554941905645\ \(0\)\
\-\ surgeon\\:\\ 0\\.045981554941905645\ \(0\)\
\-\ mammogram\\:\\ 0\\.04521133507720815\ \(0\)\
\-\ comparison\\:\\ 0\\.045106913360033106\ \(0\)\
\-\ fatty\\:\\ 0\\.045003788840619514\ \(0\)\
\-\ 95\\:\\ 0\\.0449019296846803\ \(0\)\
\-\ walls\\:\\ 0\\.04441057817810438\ \(0\)\
\-\ characteristics\\:\\ 0\\.04342221677600848\ \(0\)\
\-\ definitive\\:\\ 0\\.043254505676874444\ \(0\)\
\-\ on\\:\\ 0\\.04290543734277513\ \(0\)\
\-\ poorly\\:\\ 0\\.042770791169050144\ \(0\)\
\-\ almost\\:\\ 0\\.04253910867931992\ \(0\)\
\-\ potential\\:\\ 0\\.0423137169955589\ \(0\)\
\-\ invasion\\:\\ 0\\.042239926135845846\ \(0\)\
\-\ become\\:\\ 0\\.042022409314706216\ \(0\)\
\-\ gross\\:\\ 0\\.042022409314706216\ \(0\)\
\-\ dense\\:\\ 0\\.041740978395348814\ \(0\)\
\-\ end\\:\\ 0\\.04167208657210579\ \(0\)\
\-\ 75\\:\\ 0\\.041535994719996014\ \(0\)\
\-\ current\\:\\ 0\\.0414687764008525\ \(0\)\
\-\ form\\:\\ 0\\.04140209799371578\ \(0\)\
\-\ those\\:\\ 0\\.04052081793323475\ \(0\)\
\-\ american\\:\\ 0\\.04040222424405734\ \(0\)\
\-\ by\\:\\ 0\\.0402187672919436\ \(0\)\
\-\ their\\:\\ 0\\.03930108713997291\ \(0\)\
\-\ and\\:\\ 0\\.03914074815631469\ \(0\)\
\-\ be\\:\\ 0\\.038419495527245315\ \(0\)\
\-\ site\\:\\ 0\\.03819258735952333\ \(0\)\
\-\ involved\\:\\ 0\\.03797001592958849\ \(0\)\
\-\ procedure\\:\\ 0\\.03775325643336455\ \(0\)\
\-\ films\\:\\ 0\\.037500401848792\ \(0\)\
\-\ routine\\:\\ 0\\.03667154408195913\ \(0\)\
\-\ measuring\\:\\ 0\\.036634065837454745\ \(0\)\
\-\ irregular\\:\\ 0\\.036559613167476454\ \(0\)\
\-\ an\\:\\ 0\\.03621625332173771\ \(0\)\
\-\ system\\:\\ 0\\.03612639746594598\ \(0\)\
\-\ third\\:\\ 0\\.03605634289782291\ \(0\)\
\-\ are\\:\\ 0\\.03593760895171962\ \(0\)\
\-\ at\\:\\ 0\\.035772639760825044\ \(0\)\
\-\ about\\:\\ 0\\.035451113387026875\ \(0\)\
\-\ diagnosed\\:\\ 0\\.03430217798324175\ \(0\)\
\-\ pt\\:\\ 0\\.03407930776384344\ \(0\)\
\-\ defined\\:\\ 0\\.033782314829675836\ \(0\)\
\-\ identified\\:\\ 0\\.033572804225577436\ \(0\)\
\-\ 25\\:\\ 0\\.03354698331189047\ \(0\)\
\-\ because\\:\\ 0\\.033095435434214664\ \(0\)\
\-\ new\\:\\ 0\\.032760462501261696\ \(0\)\
\-\ size\\:\\ 0\\.0320635882487748\ \(0\)\
\-\ first\\:\\ 0\\.03195647170376973\ \(0\)\
\-\ cases\\:\\ 0\\.03185071973788459\ \(0\)\
\-\ surrounding\\:\\ 0\\.03158190815268904\ \(0\)\
\-\ out\\:\\ 0\\.03112665083964967\ \(0\)\
\-\ no\\:\\ 0\\.030798161261927425\ \(0\)\
\-\ found\\:\\ 0\\.030640392838517546\ \(0\)\
\-\ approximately\\:\\ 0\\.03021549411055993\ \(0\)\
\-\ changes\\:\\ 0\\.02861896627734227\ \(0\)\
\-\ through\\:\\ 0\\.028188888605879203\ \(0\)\
\-\ presented\\:\\ 0\\.02761434750494387\ \(0\)\
\-\ common\\:\\ 0\\.026855314027948433\ \(0\)\
\-\ than\\:\\ 0\\.026843808250559036\ \(0\)\
\-\ patients\\:\\ 0\\.026639385462815475\ \(0\)\
\-\ more\\:\\ 0\\.02600257745484074\ \(0\)\
\-\ is\\:\\ 0\\.025936595418033868\ \(0\)\
\-\ post\\:\\ 0\\.025766987810422082\ \(0\)\
\-\ into\\:\\ 0\\.025172732484587432\ \(0\)\
\-\ tumor\\:\\ 0\\.024769048146212728\ \(0\)\
\-\ woman\\:\\ 0\\.024662276036909108\ \(0\)\
\-\ most\\:\\ 0\\.024644613440761867\ \(0\)\
\-\ other\\:\\ 0\\.02459185001912413\ \(0\)\
\-\ diagnosis\\:\\ 0\\.024548135241658015\ \(0\)\
\-\ posterior\\:\\ 0\\.0244873187274735\ \(0\)\
\-\ it\\:\\ 0\\.02424000604125508\ \(0\)\
\-\ but\\:\\ 0\\.023416777024395118\ \(0\)\
\-\ female\\:\\ 0\\.022850635509946413\ \(0\)\
\-\ within\\:\\ 0\\.021809931904330615\ \(0\)\
\-\ has\\:\\ 0\\.021630066000205686\ \(0\)\
\-\ that\\:\\ 0\\.02054999181146805\ \(0\)\
\-\ disease\\:\\ 0\\.01987765428881109\ \(0\)\
\-\ as\\:\\ 0\\.019023904294237604\ \(0\)\
\-\ from\\:\\ 0\\.018807121692857056\ \(0\)\
\-\ not\\:\\ 0\\.018694352537900374\ \(0\)\
